SALL4 and cholangiocarcinoma: Given the validated SALL4 expression in human CCA, subset of HCC and mixed and/or combined HCC–CCA, we have included following murine liver cancer subtypes in our assessment: murine CCA, HCC, cHCC-CCA, and mHCC/CCA generated by distinct oncogenic drivers (Fig. 1A).